{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:44:00Z","timestamp":1795113840120,"version":"4.10.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470975"],"award-info":[{"award-number":["32470975"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"start-up grants of Nanjing Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70934-x","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:17:10Z","timestamp":1774282630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pentose phosphate pathway fuels cGAS-STING signalling to boost function of intratumoral conventional dendritic cells"],"prefix":"10.1038","volume":"17","author":[{"given":"Ben","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglei","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongchang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhekai","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7200-3639","authenticated-orcid":false,"given":"Ranran","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4489-1143","authenticated-orcid":false,"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"70934_CR1","doi-asserted-by":"crossref","unstructured":"Zou, W., Wolchok, J. D. & Chen, L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy Mechanisms, response biomarkers,and combinations.pdf. Sci. Transl. Med. 8, 328rv4 (2016).","DOI":"10.1126\/scitranslmed.aad7118"},{"key":"70934_CR2","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma, P. et al. Immune checkpoint therapy\u2014current perspectives and future directions. Cell 186, 1652\u20131669 (2023).","journal-title":"Cell"},{"key":"70934_CR3","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","volume":"184","author":"G Morad","year":"2021","unstructured":"Morad, G., Helmink, B. A., Sharma, P. & Wargo, J. A. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell 184, 5309\u20135337 (2021).","journal-title":"Cell"},{"key":"70934_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek, S. K. et al. Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 20, 7\u201324 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"70934_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.ccell.2019.05.005","volume":"35","author":"J Qiao","year":"2019","unstructured":"Qiao, J. et al. Targeting tumors with IL-10 prevents dendritic cell-mediated CD8+ T cell apoptosis. Cancer Cell 35, 901\u2013915.e904 (2019).","journal-title":"Cancer Cell"},{"key":"70934_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","volume":"31","author":"S Spranger","year":"2017","unstructured":"Spranger, S., Dai, D., Horton, B. & Gajewski, T. F. Tumor-residing Batf3 dendritic cells are required for Effector T Cell Trafficking and Adoptive T Cell Therapy. Cancer Cell 31, 711\u2013723.e714 (2017).","journal-title":"Cancer Cell"},{"key":"70934_CR7","doi-asserted-by":"publisher","unstructured":"Heras-Murillo, I., Ad\u00e1n-Barrientos, I., Gal\u00e1n, M., Wculek, S. K. & Sancho, D. Dendritic cells as orchestrators of anticancer immunity and immunotherapy. Nat. Rev. Clin. Oncol., https:\/\/doi.org\/10.1038\/s41571-024-00859-1 (2024).","DOI":"10.1038\/s41571-024-00859-1"},{"key":"70934_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","volume":"620","author":"C Guo","year":"2023","unstructured":"Guo, C. et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature 620, 200\u2013208 (2023).","journal-title":"Nature"},{"key":"70934_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/imr.13215","volume":"317","author":"Z You","year":"2023","unstructured":"You, Z. & Chi, H. Lipid metabolism in dendritic cell biology. Immunol. Rev. 317, 137\u2013151 (2023).","journal-title":"Immunol. Rev."},{"key":"70934_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O\u2019Donnell","year":"2018","unstructured":"O\u2019Donnell, J. S., Teng, M. W. L. & Smyth, M. J. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol. 16, 151\u2013167 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"70934_CR11","doi-asserted-by":"publisher","unstructured":"Katopodi, T. et al. Tumor-infiltrating dendritic cells: decisive roles in cancer immunosurveillance, immunoediting, and tumor T cell tolerance. Cells 11, https:\/\/doi.org\/10.3390\/cells11203183 (2022).","DOI":"10.3390\/cells11203183"},{"key":"70934_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","volume":"25","author":"M Roerden","year":"2025","unstructured":"Roerden, M. & Spranger, S. Cancer immune evasion, immunoediting and intratumour heterogeneity. Nat. Rev. Immunol. 25, 353\u2013369 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"70934_CR13","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/s41590-024-01932-8","volume":"25","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Tumor editing suppresses innate and adaptive antitumor immunity and is reversed by inhibiting DNA methylation. Nat. Immunol. 25, 1858\u20131870 (2024).","journal-title":"Nat. Immunol."},{"key":"70934_CR14","doi-asserted-by":"publisher","unstructured":"Tang, H. et al. Rescuing dendritic cell interstitial motility sustains antitumour immunity. Nature, https:\/\/doi.org\/10.1038\/s41586-025-09202-9 (2025).","DOI":"10.1038\/s41586-025-09202-9"},{"key":"70934_CR15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41423-021-00753-1","volume":"19","author":"SH M\u00f8ller","year":"2021","unstructured":"M\u00f8ller, S. H., Wang, L. & Ho, P.-C. Metabolic programming in dendritic cells tailors immune responses and homeostasis. Cell. Mol. Immunol. 19, 370\u2013383 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"70934_CR16","doi-asserted-by":"publisher","unstructured":"Peng, X., He, Y., Huang, J., Tao, Y. & Liu, S. Metabolism of dendritic cells in tumor microenvironment: for immunotherapy. Front. Immunol. 12, https:\/\/doi.org\/10.3389\/fimmu.2021.613492 (2021).","DOI":"10.3389\/fimmu.2021.613492"},{"key":"70934_CR17","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.molcel.2020.12.024","volume":"81","author":"Z Hu","year":"2021","unstructured":"Hu, Z. et al. SENP3 senses oxidative stress to facilitate STING-dependent dendritic cell antitumor function. Mol. Cell 81, 940\u2013952.e945 (2021).","journal-title":"Mol. Cell"},{"key":"70934_CR18","doi-asserted-by":"publisher","unstructured":"Hu, Z. et al. Glycolysis drives STING signaling to facilitate dendritic cell antitumor function. J. Clin. Investig. 133, https:\/\/doi.org\/10.1172\/jci166031 (2023).","DOI":"10.1172\/jci166031"},{"key":"70934_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader, J. E., Voss, K. & Rathmell, J. C. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol. Cell 78, 1019\u20131033 (2020).","journal-title":"Mol. Cell"},{"key":"70934_CR20","doi-asserted-by":"crossref","unstructured":"Hao, M. et al. Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy. Sci. Transl. Med. 12, eaay9518 (2020).","DOI":"10.1126\/scitranslmed.aaz6667"},{"key":"70934_CR21","doi-asserted-by":"publisher","unstructured":"Ge, T. et al. The role of the pentose phosphate pathway in diabetes and cancer. Front. Endocrinol. 11, https:\/\/doi.org\/10.3389\/fendo.2020.00365 (2020).","DOI":"10.3389\/fendo.2020.00365"},{"key":"70934_CR22","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","volume":"5","author":"T TeSlaa","year":"2023","unstructured":"TeSlaa, T., Ralser, M., Fan, J. & Rabinowitz, J. D. The pentose phosphate pathway in health and disease. Nat. Metab. 5, 1275\u20131289 (2023).","journal-title":"Nat. Metab."},{"key":"70934_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41590-020-00829-6","volume":"22","author":"M Gu","year":"2021","unstructured":"Gu, M. et al. NF-\u03baB-inducing kinase maintains T cell metabolic fitness in antitumor immunity. Nat. Immunol. 22, 193\u2013204 (2021).","journal-title":"Nat. Immunol."},{"key":"70934_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cmet.2023.12.010","volume":"36","author":"X Si","year":"2024","unstructured":"Si, X. et al. Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation. Cell Metab. 36, 176\u2013192.e110 (2024).","journal-title":"Cell Metab."},{"key":"70934_CR25","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1038\/s41590-024-01963-1","volume":"25","author":"GJ Markowitz","year":"2024","unstructured":"Markowitz, G. J. et al. Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy. Nat. Immunol. 25, 1884\u20131899 (2024).","journal-title":"Nat. Immunol."},{"key":"70934_CR26","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cell.2019.09.035","volume":"179","author":"CC Brown","year":"2019","unstructured":"Brown, C. C. et al. Transcriptional basis of mouse and human dendritic cell heterogeneity. Cell 179, 846\u2013863.e824 (2019).","journal-title":"Cell"},{"key":"70934_CR27","doi-asserted-by":"publisher","unstructured":"Gerhard, G. M., Bill, R., Messemaker, M., Klein, A. M. & Pittet, M. J. Tumor-infiltrating dendritic cell states are conserved across solid human cancers. J. Exp. Med. 218, https:\/\/doi.org\/10.1084\/jem.20200264 (2021).","DOI":"10.1084\/jem.20200264"},{"key":"70934_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442\u2013459.e429 (2020).","journal-title":"Cell"},{"key":"70934_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","volume":"99","author":"R F\u00f6rster","year":"1999","unstructured":"F\u00f6rster, R. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23\u201333 (1999).","journal-title":"Cell"},{"key":"70934_CR30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","volume":"30","author":"EW Roberts","year":"2016","unstructured":"Roberts, E. W. et al. Critical role for CD103+\/CD141+ dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma. Cancer Cell 30, 324\u2013336 (2016).","journal-title":"Cancer Cell"},{"key":"70934_CR31","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.immuni.2013.08.028","volume":"39","author":"Y Gao","year":"2013","unstructured":"Gao, Y. et al. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 39, 722\u2013732 (2013).","journal-title":"Immunity"},{"key":"70934_CR32","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1084\/jem.20021263","volume":"196","author":"G Schiavoni","year":"2002","unstructured":"Schiavoni, G. et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8\u03b1+ dendritic cells.  J. Exp. Med. 196, 1415\u20131425 (2002).","journal-title":"J. Exp. Med."},{"key":"70934_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-020-2134-y","volume":"580","author":"B Maier","year":"2020","unstructured":"Maier, B. et al. A conserved dendritic-cell regulatory program limits antitumour immunity. Nature 580, 257\u2013262 (2020).","journal-title":"Nature"},{"key":"70934_CR34","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829\u2013845.e820 (2019).","journal-title":"Cell"},{"key":"70934_CR35","doi-asserted-by":"crossref","unstructured":"Lee, C. Y. C. et al. Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity. Nat. Commun. 15, 6035 (2024).","DOI":"10.1038\/s41467-024-44787-1"},{"key":"70934_CR36","doi-asserted-by":"crossref","unstructured":"Ng, I.-I. et al. Targeting WEE1 in tumor-associated dendritic cells potentiates antitumor immunity via the cGAS\/STING pathway. Cell Rep. 44, 412\u2013427 (2025).","DOI":"10.1016\/j.celrep.2025.115733"},{"key":"70934_CR37","doi-asserted-by":"publisher","unstructured":"Wu, Z. et al. Advances in the optimization of central carbon metabolism in metabolic engineering. Microb. Cell Fact. 22, https:\/\/doi.org\/10.1186\/s12934-023-02090-6 (2023).","DOI":"10.1186\/s12934-023-02090-6"},{"key":"70934_CR38","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1124\/pr.119.018762","volume":"72","author":"MA Felmlee","year":"2020","unstructured":"Felmlee, M. A. et al. Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease. Pharmacol. Rev. 72, 466\u2013485 (2020).","journal-title":"Pharmacol. Rev."},{"key":"70934_CR39","doi-asserted-by":"publisher","unstructured":"Hwang, S. et al. Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator. Nat. Commun. 9, https:\/\/doi.org\/10.1038\/s41467-018-06447-z (2018).","DOI":"10.1038\/s41467-018-06447-z"},{"key":"70934_CR40","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1084\/jem.20161524","volume":"214","author":"Y Xiao","year":"2017","unstructured":"Xiao, Y. et al. The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. J. Exp. Med. 214, 1493\u20131507 (2017).","journal-title":"J. Exp. Med."},{"key":"70934_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41586-025-09000-3","volume":"643","author":"J Zhou","year":"2025","unstructured":"Zhou, J. et al. STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity. Nature 643, 519\u2013528 (2025).","journal-title":"Nature"},{"key":"70934_CR42","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng, L. et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity 41, 843\u2013852 (2014).","journal-title":"Immunity"},{"key":"70934_CR43","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","volume":"54","author":"\u00c1 de Mingo Pulido","year":"2021","unstructured":"de Mingo Pulido, \u00c1. et al. The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake. Immunity 54, 1154\u20131167.e1157 (2021).","journal-title":"Immunity"},{"key":"70934_CR44","doi-asserted-by":"publisher","unstructured":"Li, G. et al. cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors. Cell. Mol. Life Sci. 81, https:\/\/doi.org\/10.1007\/s00018-024-05191-6 (2024).","DOI":"10.1007\/s00018-024-05191-6"},{"key":"70934_CR45","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41590-020-0699-0","volume":"21","author":"M Jia","year":"2020","unstructured":"Jia, M. et al. Redox homeostasis maintained by GPX4 facilitates STING activation. Nat. Immunol. 21, 727\u2013735 (2020).","journal-title":"Nat. Immunol."},{"key":"70934_CR46","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"S-R Woo","year":"2014","unstructured":"Woo, S.-R. et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41, 830\u2013842 (2014).","journal-title":"Immunity"},{"key":"70934_CR47","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786\u2013791 (2013).","journal-title":"Science"},{"key":"70934_CR48","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","volume":"339","author":"J Wu","year":"2013","unstructured":"Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826\u2013830 (2013).","journal-title":"Science"},{"key":"70934_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tibs.2016.09.009","volume":"42","author":"AM Pedley","year":"2017","unstructured":"Pedley, A. M. & Benkovic, S. J. A New View into the Regulation of Purine Metabolism: The Purinosome. Trends Biochem.Sci. 42, 141\u2013154 (2017).","journal-title":"Trends Biochem.Sci."},{"key":"70934_CR50","doi-asserted-by":"publisher","unstructured":"Zhou, W. et al. Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. Nat. Commun. 11, https:\/\/doi.org\/10.1038\/s41467-020-17512-x (2020).","DOI":"10.1038\/s41467-020-17512-x"},{"key":"70934_CR51","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","volume":"19","author":"M Feng","year":"2019","unstructured":"Feng, M. et al. Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat. Rev. Cancer 19, 568\u2013586 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"70934_CR52","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.ccell.2023.05.005","volume":"41","author":"L Fang","year":"2023","unstructured":"Fang, L. et al. Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity. Cancer Cell 41, 1118\u20131133.e1112 (2023).","journal-title":"Cancer Cell"},{"key":"70934_CR53","doi-asserted-by":"publisher","unstructured":"Jia, M. et al. Myristic acid as a checkpoint to regulate STING-dependent autophagy and interferon responses by promoting N-myristoylation. Nat. Commun. 14, https:\/\/doi.org\/10.1038\/s41467-023-36332-3 (2023).","DOI":"10.1038\/s41467-023-36332-3"},{"key":"70934_CR54","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.immuni.2023.09.012","volume":"56","author":"C Zhao","year":"2023","unstructured":"Zhao, C. et al. Polyamine metabolism controls B-to-Z DNA transition to orchestrate DNA sensor cGAS activity. Immunity 56, 2508\u20132522.e2506 (2023).","journal-title":"Immunity"},{"key":"70934_CR55","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s43018-020-0075-x","volume":"1","author":"SA Oh","year":"2020","unstructured":"Oh, S. A. et al. PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer. Nat. Cancer 1, 681\u2013691 (2020).","journal-title":"Nat. Cancer"},{"key":"70934_CR56","doi-asserted-by":"publisher","unstructured":"Peng, Q. et al. PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade. Nat. Commun. 11, https:\/\/doi.org\/10.1038\/s41467-020-18570-x (2020).","DOI":"10.1038\/s41467-020-18570-x"},{"key":"70934_CR57","doi-asserted-by":"publisher","unstructured":"Xiao, K. et al. PD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapy. Cell Rep. 43, https:\/\/doi.org\/10.1016\/j.celrep.2024.114868 (2024).","DOI":"10.1016\/j.celrep.2024.114868"},{"key":"70934_CR58","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ccell.2025.02.014","volume":"43","author":"H Song","year":"2025","unstructured":"Song, H. et al. Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy. Cancer Cell 43, 503\u2013518.e510 (2025).","journal-title":"Cancer Cell"},{"key":"70934_CR59","doi-asserted-by":"crossref","unstructured":"Liu, W.-J. et al. Elevated NOX4 promotes tumorigenesis and acquired EGFR-TKIs resistance via enhancing IL-8\/PD-L1 signaling in NSCLC. Drug Resist. Updat. 70, 100987 (2023).","DOI":"10.1016\/j.drup.2023.100987"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70934-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:25:48Z","timestamp":1778711148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70934-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70934"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70934-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4342"}}